AzTrials
AzTrials

Perinatal Mental HealthNCT04107389

Developing an Evidence Base for the Use of Art Psychotherapy Within a Perinatal Mental Health Service

A study testing Art Psychotherapy, Art Therapy and Wait List in people with Perinatal Mental Health, run by University of Derby at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary Outcomes: To measure the impact of art therapy within this specific perinatal client group Attempt to establish a quality evidence base for the intervention within this setting Secondary Outcomes: Capture the participants lived experience of Art Therapy Measure participant interaction with art materials during… Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Perinatal Mental Health
What is being tested?
Art Psychotherapy, Art Therapy and Wait List
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
1 siteUnited Kingdom
Study dates
26 May 2021to 26 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Individuals admitted to the perinatal Mother and Baby unit who are able to speak English and who consent to take part.

Who cannot join

  • Individuals who do not speak English.
  • Individuals who do not consent to take part.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • The Beeches, Royal Derby Hospital Site

    Derby, Derbyshire, DE22 3WQ

Other trials in United Kingdom

About this study

Primary Outcomes:

  • To measure the impact of art therapy within this specific perinatal client group
  • Attempt to establish a quality evidence base for the intervention within this setting
Read more

Secondary Outcomes:

  • Capture the participants lived experience of Art Therapy
  • Measure participant interaction with art materials during Art Therapy intervention
  • Measure any changes in mental wellbeing of the participants during Art Therapy intervention
  • Monitor patient reported quality of life during Art Therapy intervention
  • Record changes in mother-infant interaction during Art Therapy intervention

Hypotheses:

  • The measures will show an improvement in mental wellbeing, quality of life and mother-infant interaction in participants who receive the Art Therapy intervention compared to the baseline measurements taken at the start of the intervention.
  • The wait-list control group who have not yet received the intervention will display lower scores on the above measures, prior to receiving the Art Therapy intervention.

The aim of this study is to measure the impact of art therapy within this specific perinatal client group in order to attempt to establish an evidence base for the intervention within this setting; while following a primarily quantitative approach with complimentary qualitative elements. Art Therapy is a form of psychotherapy, based upon the premise of utilising art materials as a form of expression and communication; the roots of the theoretical approach lie in a psychodynamic approach to working with the unconscious.

Read the detailed description

Methodology:

I intend to use a wait-list control group, whereby following admission to the unit a patient will follow the recruitment process detailed below, only after the recruitment process has been completed in full would consenting patients be randomised to an intervention group which will begin Art Therapy sessions in due course, or to a wait-list control group for a minimum of two weeks and a maximum of six weeks. The intervention group members will receive the Art Therapy intervention, while the waitlist control group are fully aware of the research and are waiting to receive it at a later date. The waitlist participants will be made fully aware that if they are discharged before therapy has become available to them, or if they reach the maximum term of 6 weeks on the waiting list, then they may not receive the intervention. Participants who reach the maximum term of 6 weeks on the waiting list while waiting for therapy availability will be withdrawn from the research and offered a debrief meeting in order to answer any remaining questions about the research. This maximum six week term is based upon the six week average duration of patient stay within the unit.

I am a qualified Art Psychotherapist and will be using a non-directive approach in order that the clients will lead their interactions with the art materials and with the therapy process.

Art Therapists are governed by the British Association of Art Therapists and the Health and Care Professions council who each set standards of professional therapy delivery. I will establish and facilitate a safe therapeutic provision of weekly individual Art Therapy sessions for patients of the unit.

I will work closely with the unit staff team in order to introduce and create a shared understanding about the therapeutic intentions of the art therapy provision. The additional benefit of employing a non-directive, client centred approach to Art Therapy sessions is that this will ensure that the clients themselves have key influence over the theme and artistic content of therapy sessions. The client presentation will then be analysed using a series of recognised quantitative scales to monitor client progress, therefore minimising the influence of the multiple therapists on the research data and increasing the quality of the data.

There will be an initial assessment period within the intervention. This will consist of one session of 50 minute duration, during which an assessment will be made about the clients interaction with art materials. This will be conducted by utilising the Hyland Moon approach of categorising art materials as high or low structure based on their properties. High structure materials being easy to control versus low structure materials being more fluid in nature and therefore more challenging to work with. The differing art making experiences and client interactions that these varying art materials can produce will be valuable in gaining an insight into the clients functioning, in order to facilitate an assessment of the appropriateness of the intervention within the context of each individuals presentation and diagnoses. Following assessment, both the client and the therapist will have the opportunity to either withdraw or consent to continuation of the intervention. Should the therapist determine following assessment that Art Therapy is not appropriate for the patient, for example in the instance that the patients presentation is so severe that an offering of Art Therapy may pose a risk to the therapist or the patient, or that the level of willingness to engage in the assessment phase (in spite of consent previously given) is so lacking that a continued offering is not sustainable, then the patient will be withdrawn from the research. In this instance, a letter will be provided to the patient, inviting them to return for a re-assessment for Art Therapy sessions, at such point as they feel ready to do so in future after a minimum period of two weeks have elapsed since prior assessment. The length of each clients engagement with the Art Therapy sessions, i.e. number of sessions provided, will vary due to the nature of the population. However, the average stay for a client within the unit is 42 days and they would be eligible for inclusion in the research from the point of admission, subject to consent and recruitment procedures. The intention will be to offer a series of five sessions of therapy following assessment. Should the patient be discharged prior to the end of therapy, the option will be offered of returning to the unit for the remaining sessions as an outpatient. The use of qualitative and quantitative data collection methods will account for capturing the complexity of the intervention. The provision of this intervention within the unit is over and above what the unit's "care as usual" plan is, because an Art therapy service does not currently exist in the setting. The following measurement scales are already in use as standard practice within the perinatal unit, therefore staff are comfortable with their application and credibility within the NHS setting. In order to honour the multidisciplinary approach to working with the patients, I therefore intend to have continuity in measures and will employ all of these scales at intervals throughout the participants engagement in therapy sessions.

Quantitative measures:

The use of quantitative measures within the research will mitigate against bias and the influencer of the researcher on the research findings, by presenting statistical data which will then be analysed using IBM SPSS Statistics software and reviewed by my supervisors. In addition to this, an element of influence will be eliminated via the fact that student therapists will also be delivering the intervention.

Application of scales:

The weekly questionnaires (ReQol10 and Bethlem Mother-Infant Interaction Scale) will be administered by the unit care team as part of their standard care plan, the researcher has requested permission from the patient (within the patient consent form) to access the patients medical records to withdraw the weekly scores from these questionnaires, for anonymous inclusion within the research data. This will avoid patients being asked to complete weekly duplicates of these questionnaires that they will already be completing with the unit care team. The researcher and therapists will already be authorised to have access to patient medical records under the terms of the honorary contract as provided by the unit, in order to record brief therapy notes.

Statistical Analysis:

Statistical analysis of the quantitative data collected will be conducted by the researcher, via IBM SPSS Statistics software, using Repeated Measures One-Way ANOVA to analyse the data collected from weekly questionnaires, alongside t-test and One-Way ANOVA analyses which will be applied to the questionnaires used during the assessment phase and at the end of therapy engagement.

Please see the Participant Timeline diagram and Table of Measures attached for additional clarity regarding administration of measures.

Qualitative measure:

In addition to this, I intend to employ the qualitative measure of an end of therapy Reflect Interview which will be recreated with each consenting participant, using the same set of semi-structured interview questions as written by the researcher and AIR (Audio Image Recording - as developed by N. Springham) piece as a way of commemorating and bringing an end point to the work done during Art Therapy sessions. As this is a qualitative measure and has been tested for feasibility as such, the interview questions are semi-structured in order to allow for the client to fully express their lived experience of therapy. I will undertake collaborative editing with client of the AIR recording, in order to demonstrate that I am working to reduce the bias / outside influence on the final piece, this will be achieved by giving the client an opportunity to state at the end of the interview whether they wish me to remove any sections of audio or add anything in. Data will be collected from the AIR's via transcription and analysis (by the researcher) of the transcripts for recurring words and themes within each patients interview.

In spite of the cohort being relatively small and the research undertaken over a relatively short timescale, a large amount of pre and post intervention data may be produced. This will require statistical analysis in order to attempt to determine statistically significant change in the clients presentation. I intend to code all qualitative data gathered using a 6-step framework of thematic analysis devised by Braun \& Clarke, during which I will code interview transcripts and then identify both semantic and latent themes within the coding. Due to the volume of qualitative data in the form of AIR transcripts that I anticipate being generated during the research, I intend to use professional and encrypted Nvivo software, provided by the University to aid the data analysis process.

The end of trial date will be signified by the completion of the minimum term of one full year of data collection.

In order that the population of participants are randomly, yet evenly allocated into wait-list and treatment groups, a blocked randomisation process will be applied. This will be conducted via Sealed Envelope, a website facility which can be customised to produce a list of participants and their randomly allocated group. In addition, the website will allocate each participant with a randomly generated code consisting of two letters and one number, it is ensured that no participant code within the list can ever be repeated. Participant codes will be used in place of names on all questionnaires, the AIR audio file and all data records in order to preserve anonymity. The allocation concealment mechanism within the randomisation process will be that the randomisation list will be produced and held by the Director of Studies and Supervisor, Jamie Bird.

Each time a participant has completed the introduction and recruitment process and given their consent to be involved in the research, the clinician-researcher will then obtain from the Director of Studies the next available participant code for that individual and establish whether they will be allocated to the wait-list or treatment group. Throughout the study, all participants shall remain anonymous to the Director of Studies and shall not be given any identifying information about participants. A record of participant names and the randomisation log of codes will be recorded in the site file which will be stored in an encrypted electronic format and will only be accessed by the lead clinician-researcher. In addition to this, including the varying size blocked element within the randomisation process adds another layer of allocation concealment as the clinician-researcher will be unable to predict the next allocation outcome. The benefit of this would be that the participants would be randomised and their clinical presentation could be measured in comparison as a control group to isolate the effect of the Art Therapy intervention as the independent variable. Additionally, this approach is considered to be ethically preferable to a control group which denies participants access to an intervention for the entirety of a research study.

Being tested
Art Psychotherapy, Art Therapy, Wait List
Keywords
Art Psychotherapy, Art Therapy, Perinatal Mental Health, Mother and baby unit, Mental health and wellbeing, Pregnancy, Post-Partum, Creative Intervention, Randomised Control Trial, ReQol, WEMWBS
Medical subject headings
Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Art Psychotherapy, Art TherapyBehavioural

    Art Therapy is a form of psychotherapy, based upon the premise of utilising art materials as a form of expression and communication; the roots of the theoretical approach lie in a psychodynamic approach to working with the unconscious.

  • Wait ListBehavioural

    Wait list control group. Participants randomised to Wait List group or Intervention group.

Study groups in NCT04107389
Study groupRoleWhat they receive
Intervention GroupActive comparatorReceives Art Therapy assessment and intervention
Receives: Behavioral: Art Psychotherapy, Art Therapy
Wait List Control GroupActive comparatorAdded to wait list to receive intervention at a later date, participant is made aware of this
Receives: Behavioral: Wait List

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measure any changes in mental wellbeing during the term of the Art Therapy intervention.

    Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS), 14 items - sensitive to changes in mental wellbeing at the individual level. This scale will be used once during the one week assessment and once at the end of the five week therapy engagement. The total score is obtained by summing the score for each of the 14 items. The scoring range for each item is from 1 - 5 and the total score is from 14-70. A score of 40 and below corresponded to probable depression and a score of 44 and below to possible depression.

    Measured: Duration of therapeutic intervention within unit - approximately one year.

  2. Monitor patient reported quality of life during the term of the Art Therapy intervention.

    ReQol20 (Recovering Quality of Life) - Patient reported outcome measure. To assess the quality of life for people with varying mental health conditions. Used once during the one week assessment period and once at the end of the five week therapy engagement.

    A ReQoL20 score between 0 and 49 is considered as falling within the clinical range. A score of 50 and above is considered as falling within the range of the general population.

    Measured: Duration of therapeutic intervention within unit - approximately one year.

  3. Monitor patient reported quality of life during the term of the Art Therapy intervention and during the wait-list period.

    ReQol10 (Recovering Quality of Life) - Patient reported outcome measure. To assess the quality of life for people with varying mental health conditions. Used once during the one week assessment period and once at the end of the five week therapy engagement. The ReQol10 scale which includes 10 questions, used weekly for the duration of the engagement in therapy and during the wait-list period. A ReQoL-10 score between 0 and 24 is considered as falling within the clinical range. A score of 25 and above is considered as falling within the range of the general population

    Measured: Duration of therapeutic intervention within unit - approximately one year.

  4. Monitor changes in mother-infant interaction during the term of the Art Therapy intervention and during the wait-list period.

    Bethlem Mother-Infant Interaction Scale - Assesses disturbances of mother-infant interaction. This scale will be used weekly for the duration of the engagement in therapy (maximum five week duration available) and during the wait-list period (a minimum duration of two weeks and maximum of six weeks). 7-item, 5-point rating scale used to measure mother-infant adjustment. Scoring is rated from 0 to 4, with 0 indicating the mother is judged to be interacting with her baby in an appropriate, sensitive and well- organised manner. A rating of 4 indicates that the mother and infant have been nursed separately for the majority of the week.

    Measured: Duration of therapeutic intervention within unit - approximately one year.

  5. Statistical analysis of change in mental wellbeing as assessed by the use of Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)

    Statistical analysis conducted by the researcher, via IBM SPSS Statistics software, using Repeated Measures One-Way ANOVA and t-test to analyse the data collected from questionnaire used during the assessment phase and at the end of therapy engagement.

    Measured: End of therapy intervention - after approximately one year of therapy work in unit.

  6. Statistical analysis of change in patient reported quality of life as assessed by the use of ReQol20 (Recovering Quality of Life)

    Statistical analysis of the quantitative data collected will be conducted by the researcher, via IBM SPSS Statistics software, using t-test and One-Way ANOVA analyses which will be applied to the questionnaires used during the assessment phase and at the end of therapy engagement.

    Measured: End of therapy intervention - after approximately one year of therapy work in unit.

  7. Statistical analysis of change in patient reported quality of life as assessed by the use of ReQol10 (Recovering Quality of Life)

    Statistical analysis of the quantitative data collected will be conducted by the researcher, via IBM SPSS Statistics software, using t-test and One-Way ANOVA analyses which will be applied to the questionnaires used weekly during the wait list and therapy intervention.

    Measured: End of therapy intervention - after approximately one year of therapy work in unit.

  8. Statistical analysis of changes in mother-infant interaction as assessed by the use of the Bethlem Mother-Infant Interaction Scale.

    Statistical analysis of the quantitative data collected will be conducted by the researcher, via IBM SPSS Statistics software, using t-test and One-Way ANOVA analyses which will be applied to the questionnaires used weekly during the wait list and therapy intervention.

    Measured: End of therapy intervention - after approximately one year of therapy work in unit.

Secondary outcomes (2)
  1. Capture the participants lived experience of Art Therapy

    Qualitative measure of a participant, therapist interview combined with discussion of the participants selected artwork. Semi-structured interview in line with the AIR (Audio Image Recording) approach as established by Neil Springham. This will provide descriptive based, qualitative outcome data which will be analysed for recurring themes in order to capture the participants experience. Themes such as discussion of improved wellbeing are anticipated.

    Measured: End of therapy intervention with each client, approximately 6 weeks

  2. Measure participant interaction with art materials during Art Therapy intervention

    During the assessment sessions, client presentation and artwork produced will be analysed using the qualitative approach of categorising art materials and observations of the clients interactions with the materials. This will be conducted by utilising the Hyland Moon approach of categorising art materials as high or low structure based on their properties. High structure materials being easy to control versus low structure materials being more fluid in nature and therefore more challenging to work with. The differing art making experiences and client interactions that these varying art materials can produce will be valuable in gaining an insight into the clients functioning, in order to facilitate an assessment of the appropriateness of the intervention within the context of each individuals presentation and diagnoses.

    Measured: Assessment phase only, first week of therapy, one week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Sep 2019
  2. Study start26 May 2021
  3. Primary completion26 May 2022
  4. Study completion26 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
I intend to use a wait-list control group, whereby following admission to the unit, consenting patients will be randomised to an intervention group which will begin Art Therapy sessions in due course, or to a wait-list control group for a minimum of two weeks and a maximum of six weeks. The intervention group members will receive the Art Therapy intervention, while the waitlist control group are fully aware of the research and are waiting to receive it at a later date. The waitlist participants will be made fully aware that if they are discharged before therapy has become available to them, or if they reach the maximum term of 6 weeks on the waiting list, then they may not receive the intervention. Participants who reach the maximum term of 6 weeks on the waiting list while waiting for therapy availability will be withdrawn from the research. This maximum six week term is based upon the six week average duration of patient stay within the unit.
Masking
None (open label)
Enrolment
8 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04107389
Sponsor's protocol ID
Stanhope 100491262
Status last verified
Jul 2022
First submitted
17 Sep 2019
Last updated
22 Jul 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Art Psychotherapy, Art Therapy and Wait List in people with Perinatal Mental Health, run by University of Derby at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measure any changes in mental wellbeing during the term of the Art Therapy intervention. (time frame: Duration of therapeutic intervention within unit - approximately one year.). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in